EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD5L as a potential immunomodulator in dengue severity

Nurhafiza Zainal, Ni Luh Ayu Megasari, Chin Kim Ling, Lee Jiang Lin, Azwani Abdullah

Journal of Vector Borne Diseases · 2026-07 · 63 (3) · 383-389

DOI: 10.4103/jvbd.jvbd_223_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vector Borne Diseases, online erschienen am 22.09.2026. Verfasst von Nurhafiza Zainal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Dengue, Immunologic Factors. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: CD5L (CD5 antigen-like) is a secreted glycoprotein involved in immune regulation, macrophage polarization, and lipid metabolism. While its role in inflammatory and bacterial diseases has been described, its function in viral infections such as dengue virus (DENV) infection remains unclear. This study aimed to evaluate serum CD5L levels in dengue-infected individuals and investigate its association with serological markers and disease severity. A cross-sectional study involving dengue-positive and dengue-negative individuals was conducted to compare serum CD5L concentrations and assess correlations with NS1, IgM, IgG status, and disease severity. Methods: Serum samples were collected from confirmed dengue-positive patients and dengue-negative controls. CD5L concentrations were quantified using enzyme-linked immunosorbent assay (ELISA) and analyzed according to serological profiles (NS1, IgM, and IgG). Two-group comparisons were performed using the Mann-Whitney U test, and multiple groups were analyzed using the Kruskal-Wallis test with Dunn’s post hoc test. A p-value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueImmunologic FactorsHumansFemaleCross-Sectional StudiesMaleImmunoglobulin GImmunoglobulin MAntibodies, ViralEnzyme-Linked Immunosorbent AssaySeverity of Illness IndexAdultBiomarkersMiddle AgedDengue VirusYoung AdultAdolescentViral Nonstructural Proteins

Stichwörter der Autor:innen

CD5Lbiomarkerdenguedisease severityimmune regulation

Substanzen

Immunoglobulin GImmunoglobulin MAntibodies, ViralImmunologic FactorsBiomarkersViral Nonstructural Proteins

Autor:innen und Institutionen

  • Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
  • Postgraduate School, Universitas Airlangga, Surabaya, Indonesia.
  • Institute for Advanced Studies, Advanced Studies Complex, Universiti Malaya, Kuala Lumpur, Malaysia.

Zitieren

APA

Zainal, N., Megasari, N. L. A., Ling, C. K., Lin, L. J., & Abdullah, A. (2026). CD5L as a potential immunomodulator in dengue severity. Journal of Vector Borne Diseases, 63(3), 383-389. https://doi.org/10.4103/jvbd.jvbd_223_25

Vancouver

Zainal N, Megasari NLA, Ling CK, Lin LJ, Abdullah A. CD5L as a potential immunomodulator in dengue severity. Journal of Vector Borne Diseases. 2026;63(3):383-389. doi:10.4103/jvbd.jvbd_223_25

BibTeX
@article{Zainal2026,
  author = {Zainal, Nurhafiza and Megasari, Ni Luh Ayu and Ling, Chin Kim and Lin, Lee Jiang and Abdullah, Azwani},
  title = {CD5L as a potential immunomodulator in dengue severity},
  journal = {Journal of Vector Borne Diseases},
  year = {2026},
  volume = {63},
  number = {3},
  pages = {383--389},
  doi = {10.4103/jvbd.jvbd_223_25}
}
Kostenlos starten →